Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.

Saved in:
Bibliographic Details
Title: Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.
Authors: Yoshida-Court K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Karpinets TV; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Mitra A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Solley TN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Dorta-Estremera S; Comprehensive Cancer Center, Cancer Biology, Department of Microbiology and Zoology, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Sims TT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Delgado Medrano AY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., El Alam MB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Ahmed-Kaddar M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Lynn EJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Sastry KJ; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Nick A; Saint Thomas Health/Ascension, Nashville, TN, United States of America.; Tennessee Oncology, Nashville, Tennessee, United States of America., Lu K; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Source: PloS one [PLoS One] 2023 Jan 06; Vol. 18 (1), pp. e0279590. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0279590